Skip to menu Skip to content Skip to footer

Traceable Theranostics: Tools for visualising drug delivery and therapeutic benefit in vivo (2012-2015)

Abstract

Cancer and related diseases have a tremendous negative impact on society - a step change in the way cancer is diagnosed and treated is required. Central to this aim is the development of therapies tailored for a particular patient. To achieve this level of care, this proposal aims to develop 'smart' biomedical devices that can diagnose, treat and monitor a therapy. This will be achieved through development of innovative strategies for 'turning-on' an imaging construct upon drug release. This approach is expected to significantly benefit the health-care system by providing a rapid feed-back loop for designing improved drug delivery strategies that result in enhanced disease targeting and consequently improved efficacy and fewer side effects.

Experts

Professor Kristofer Thurecht

Senior Group Leader and Deputy Director, Research (AIBN/CAI)
Australian Institute for Bioengineering and Nanotechnology
Kristofer Thurecht